Company J. Molner

MOLNRIPO

EE3100109034

Pharmaceuticals

Business Summary

Share class

Company contact information

Sector

Sector Generic Pharmaceuticals

Delayed Nasdaq Tallinn Other stock markets 13:43:59 17/05/2024 BST			5-day change	1st Jan Change
14.3 ^EUR	-0.69%		-0.69%	+4.00%

04-30	J. Molner AS Gains US FDA Approval for First Estonian-Developed ANDA - Lidocaine Hydrochloride Topical Solution 4%	CI
03-04	J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services	CI

JMolner AS is an Estonia-based company primarily engaged in generic drug development for specialty generic pharmaceuticals. The Company also provides analytical chemistry services and cost-saving commercial stability solutions. The Company's main focus is on the USA and Canadian markets, however it also provides its laboratory analytics services to local Estonian and European customers.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,686,001	85,986 ( 5.100 %)	0	5.100 %

J. Molner AS

Akadeemia tee 21/5

12618, Tallinn

+372 6 150 576

http://www.jmolner.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Generic Pharmaceuticals

	1st Jan change	Capi.
J. MOLNER	+4.00%	26.19M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+22.76%	44.12B
OTSUKA HOLDINGS CO., LTD.	+22.22%	22.61B
SANDOZ GROUP AG	+18.00%	15.11B
CIPLA LIMITED	+15.63%	13.61B
ZYDUS LIFESCIENCES LIMITED	+58.59%	13.34B
ONO PHARMACEUTICAL CO., LTD.	-8.98%	6.94B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+15.65%	5.75B

Generic Pharmaceuticals